BIT/1RVMD (BIT/1RVMD)

Borsa Italiana: BIT/1RVMD · EUR

€184

-1.50 (-0.8%)· Recorded snapshot

Market cap	35.8B
Net income (ttm)	-1.5B
EPS (ttm)	-€8.02
Volume	44

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -1.5B
EPS (ttm): -€8.02
Market cap: 35.8B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 13.7P50 18.9P75 26.3

Trailing P/En/a

P25 18.3P50 24.5P75 35.6

ROE-79.1

P25 2.4P50 10.6P75 22.2

ROIC-33.7

P25 5.1P50 9P75 18.8

Benchmarks · 1M

All BIT/1RVMD indicators

Market & fundamental data

Available fields

145

Groups with data

Currency

USD

Showing 145 of 145 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	United States
Country code	IT
Earnings date	2026-11-04
Employees	883
Employees change	349
Employees growth	65.36%
Enterprise value	EUR 33.4B
Exchange	Borsa Italiana
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-10-10
Fiscal year end	December
Founded	2014
Industry	Biotechnology
Is primary listing	No
ISIN number	US76155X1000
Last refreshed	2026-10-28
Market cap	EUR 35.8B
Next earnings date	2026-11-04
Price	EUR 184.45
Price currency	EUR
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-02
Symbol	bit/1RVMD
Website	https://www.revmed.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-4.35%
FCF / EV yield	-3.23%
FCF yield	-3.01%
P/B ratio	15.7x
Price / tangible book value	16.14x
Sector forward P/E	17.75x
Sector P/E	20.94x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Profit per employee	EUR -1.8M
ROA	-30.12%
ROA (5Y)	-21.66%
ROCE	-41%
ROE	-79.09%
ROE (5Y)	-39.1%
ROIC	-33.68%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	0
Net income growth years	0
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -8M
Depreciation and amortization	EUR 8.1M
EBIT	EUR -1.4B
EBITDA	EUR -1.4B
EPS	EUR -8.02
Financing cash flow	EUR 2.6B
Free cash flow	EUR -1.1B
Free cash flow minus SBC	EUR -1.3B
Gross profit	EUR -1.1B
Investing cash flow	EUR -1.2B
Net borrowing	EUR 438M
Net cash flow	EUR 362.3M
Net income	EUR -1.5B
Operating cash flow minus SBC	EUR -1.3B
Operating income	EUR -1.4B
Stock-based compensation	EUR 191.5M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	EUR 10.65
Debt / equity	0.46
Goodwill	EUR 13.1M
Interest coverage	-27.42
Long-term assets	EUR 161.2M
Long-term liabilities	EUR 1.2B
Net cash (debt)	EUR 2.4B
Net cash / market cap	6.71%
Net cash growth	56.17%
Net debt / equity	-1.05
Piotroski F-Score	1
Property, plant and equipment	EUR 146.1M
Shareholders' equity	EUR 2.3B
Tangible book value	EUR 2.2B
Tangible book value per share	EUR 10.36
Total assets	EUR 3.8B
Total cash	EUR 3.4B
Total debt	EUR 1B
Total liabilities	EUR 1.5B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current assets	EUR 3.6B
Current liabilities	EUR 318.4M
Current ratio	11.38
Net working capital	EUR -216.1M
Quick ratio	11.12
Working capital	EUR 3.2B

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-10.45%
Shareholder yield	-10.45%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	EUR 141.69
1D price change	-0.81%
1M price change	2.93%
1M total return	2.93%
1W price change	1.18%
1W total return	1.18%
1Y price change	363.44%
1Y return CAGR	363.93%
1Y total return	363.44%
20-day SMA	EUR 175.93
200-day SMA	EUR 127.28
3M price change	11.96%
3M total return	11.96%
50-day SMA	EUR 175.34
50-day SMA vs 200-day SMA	50over200
52-week high	EUR 193.20
52-week high date	2026-08-27
52-week low	EUR 39.40
52-week low date	2025-10-03
6M price change	118.28%
6M total return	118.28%
All-time high	EUR 193.20
All-time high date	2026-08-27
All-time low	EUR 29.60
All-time low date	2025-06-12
Average true range (ATR)	EUR 4.54
Average volume	61
Change from 52-week high	-4.53%
Change from 52-week low	368.15%
Change from all-time high	-4.53%
Change from all-time low	523.14%
Change from open	0.11%
Day's gap	-0.91%
Dollar volume	EUR 8,116
High price	EUR 185.00
Low price	EUR 184.25
Monthly RSI	94.8
Open price	EUR 184.25
Position in 52-week range	26.67%
Previous close	EUR 185.95
Price vs 150-day SMA	30.18%
Price vs 20-day SMA	4.84%
Price vs 200-day SMA	44.92%
Price vs 50-day SMA	5.19%
Relative volume	0.72
RSI	59.54
Sharpe ratio	2.6
Sortino ratio	5.38
Volume	44
Weekly RSI	73.53
YTD price change	173.26%
YTD total return	173.26%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	184.6M
Shares change (QoQ)	6.46%
Shares change (YoY)	10.45%
Shares held by insiders	2.17%
Shares held by institutions	90.15%
Short ratio	6.6 days

Deeper analysis on BIT/1RVMD

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BIT/1RVMD report

Is a complete BIT/1RVMD research report available?

No complete published report is available for bit/1RVMD (BIT/1RVMD) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BIT/1RVMD (BIT/1RVMD)

Price

Financial snapshot

Fair-value bridge

Latest news · BIT/1RVMD

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BIT/1RVMD indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BIT/1RVMD

Frequently asked questions